Stanford Masters chats with Moneycontrol's Viswanath Pilla to understand if there is any substance to these allegations.
Moneycontrol News
@moneycontrolcom
Stocks of Indian pharmaceutical companies tanked after the second anti-trust case against 20 pharma companies in US.
This lawsuit seeks expansion of the case as they claim to have more evidence of the wrongdoings by the company.
Stanford Masters chats with Moneycontrol's Viswanath Pilla to understand if there is any substance to these allegations.First Published on May 14, 2019 04:59 pm
